Page last updated: 2024-12-05

4-nitrophenyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-nitrophenyl acetate is a synthetic compound used as a substrate for the study of esterases, including acetylcholinesterase. It is synthesized through the reaction of 4-nitrophenol with acetic anhydride in the presence of a base, typically pyridine. The hydrolysis of 4-nitrophenyl acetate by esterases releases 4-nitrophenolate, which is a colored product that can be monitored spectrophotometrically. This makes it a useful tool for studying the kinetics and mechanisms of esterase activity. 4-nitrophenyl acetate is also used as a model substrate to study the effects of inhibitors and activators on esterase activity. It is important for research as it provides a convenient and sensitive method for studying the activity and inhibition of enzymes that hydrolyze esters.'

Cross-References

ID SourceID
PubMed CID13243
CHEMBL ID40988
CHEBI ID82635
SCHEMBL ID74985
MeSH IDM0052659

Synonyms (48)

Synonym
4-06-00-01298 (beilstein handbook reference)
unii-i902j0qh9s
i902j0qh9s ,
p-nitrophenyl acetate (van)
brn 0515874
ai3-00496
nsc 2633
einecs 212-593-5
AKOS015833423
p-nitrophenol acetate
nsc-2633
acetic acid, 4-nitrophenyl ester
acetic acid, p-nitrophenyl ester
4-nitrophenyl acetate ,
830-03-5
acetic acid p-nitrophenyl ester
wln: wnr dov1
p-nitrophenyl acetate
p-acetoxynitrobenzene
nsc2633
4-nitrophenyl acetate, esterase substrate
para-nitrophenyl acetate
N-3900
pnp-acetate
A0040
acetic acid 4-nitrophenyl ester
CHEMBL40988
chebi:82635 ,
(4-nitrophenyl) acetate
A840484
FT-0619251
phenol, p-nitro-, acetate
p-nitrophenyl acetates
p-nitrobenzene acetate
SCHEMBL74985
acetic acid 4-nitro-phenyl ester
bdbm11326
4-o2nc6h4oac
DTXSID2061191
mfcd00007326
4-nitrophenyl acetate, >=99.0% (gc)
p-acetoxy nitrobenzen
Q27156150
F31024
AS-19298
k4v ,
SY010750
CS-W017169

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"Individual plasma-converting enzyme activity was measured in 20 adult cancer patients participating in a pharmacokinetic and phase I clinical trial of a prolonged 96-h intravenous infusion of irinotecan."( Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
Band, R; Bowen, D; Cottrell, J; Grem, JL; Guemei, AA; Hehman, H; Ismail, AS; Pavlov, MV; Prudhomme, M; Takimoto, CH; Taylor, RE, 2001
)
0.31
" Pharmacokinetic variations in the relative exposure to SN-38 did not correlate with the measured carboxylesterase-converting enzyme activity nor with plasma butyrylcholinesterase activity in our patient population."( Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
Band, R; Bowen, D; Cottrell, J; Grem, JL; Guemei, AA; Hehman, H; Ismail, AS; Pavlov, MV; Prudhomme, M; Takimoto, CH; Taylor, RE, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenyl acetatesAn acetate ester obtained by formal condensation of the carboxy group of acetic acid with the hydroxy group of any phenol.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (29)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to bacteriumCarbonic anhydrase 3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 3Homo sapiens (human)
cholesterol biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
response to toxic substanceLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol effluxLiver carboxylesterase 1Homo sapiens (human)
negative regulation of cholesterol storageLiver carboxylesterase 1Homo sapiens (human)
epithelial cell differentiationLiver carboxylesterase 1Homo sapiens (human)
cholesterol homeostasisLiver carboxylesterase 1Homo sapiens (human)
reverse cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
medium-chain fatty acid metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid biosynthetic processLiver carboxylesterase 1Homo sapiens (human)
cellular response to cholesterolLiver carboxylesterase 1Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulusLiver carboxylesterase 1Homo sapiens (human)
cholesterol ester hydrolysis involved in cholesterol transportLiver carboxylesterase 1Homo sapiens (human)
positive regulation of cholesterol metabolic processLiver carboxylesterase 1Homo sapiens (human)
regulation of bile acid secretionLiver carboxylesterase 1Homo sapiens (human)
lipid catabolic processLiver carboxylesterase 1Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 3Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Homo sapiens (human)
nickel cation bindingCarbonic anhydrase 3Homo sapiens (human)
sterol esterase activityLiver carboxylesterase 1Homo sapiens (human)
methylumbelliferyl-acetate deacetylase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylesterase activityLiver carboxylesterase 1Homo sapiens (human)
carboxylic ester hydrolase activityLiver carboxylesterase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytoplasmCarbonic anhydrase 3Homo sapiens (human)
cytoplasmLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulum lumenLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
cytosolLiver carboxylesterase 1Homo sapiens (human)
lipid dropletLiver carboxylesterase 1Homo sapiens (human)
endoplasmic reticulumLiver carboxylesterase 1Homo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID646258Ratio of Kcat to Km for human recombinant carbonic anhydrase 7 C183S/C217S mutant2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID456232Activity at human recombinant CES1 expressed in baculovirus-infected Spodoptera frugiperda Sf21 cells assessed as substrate hydrolysis by fluorescence assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations.
AID315094Activity of human carbonic anhydrase 2 assessed as substrate hydrolysis2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID525928Ratio of Kcat to Km for human carbonic anhydrase 12010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of α- but not of β-, γ- and ζ-carbonic anhydrases.
AID525934Ratio of Kcat to Km for mouse carbonic anhydrase 132010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of α- but not of β-, γ- and ζ-carbonic anhydrases.
AID412236Lipophilicity, log P of the compound2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.
AID646256Ratio of Kcat to Km for human recombinant carbonic anhydrase 32012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID315102Ratio of kcat to KM for human carbonic anhydrase 12008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID646257Ratio of Kcat to Km for human recombinant carbonic anhydrase 72012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID646255Activity of S-glutathionylated form of human recombinant carbonic anhydrase 72012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID646254Activity of human recombinant carbonic anhydrase 7 C183S/C217S mutant2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID646252Activity of human recombinant carbonic anhydrase 32012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID315095Activity of mouse carbonic anhydrase 13 assessed as substrate hydrolysis2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID646259Ratio of Kcat to Km for S-glutathionylated form of human recombinant carbonic anhydrase 72012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID315103Ratio of kcat to KM for human carbonic anhydrase 22008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID315104Ratio of kcat to KM for mouse carbonic anhydrase 132008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID1149948Binding affinity to chymotrypsin (unknown origin) assessed as deacetylation1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID8206Time taken for 50% to be consumed by serum PON1 was determined2003Bioorganic & medicinal chemistry letters, May-19, Volume: 13, Issue:10
Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.
AID525931Ratio of Kcat to Km for human carbonic anhydrase 22010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of α- but not of β-, γ- and ζ-carbonic anhydrases.
AID155743Inhibitory activity against human serum paraoxonase (PON1); Not active2003Bioorganic & medicinal chemistry letters, May-19, Volume: 13, Issue:10
Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.
AID646253Activity of human recombinant carbonic anhydrase 72012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
AID315093Activity of human carbonic anhydrase 1 assessed as substrate hydrolysis2008Bioorganic & medicinal chemistry letters, Apr-01, Volume: 18, Issue:7
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (259)

TimeframeStudies, This Drug (%)All Drugs %
pre-199071 (27.41)18.7374
1990's43 (16.60)18.2507
2000's66 (25.48)29.6817
2010's66 (25.48)24.3611
2020's13 (5.02)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.75 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index59.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.38%)5.53%
Reviews1 (0.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other263 (99.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]